Welcome to Gen-Probe

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human diseases and screen donated human blood. NATs harness the power of biotechnology to detect diseases more rapidly and/or accurately than older testing methods.



GPRO 59.88 -1.19
Aug 7 2008 4:00PM
MORE INFO

July 31, 2008

Gen-Probe Reports Strong Financial Results for Second Quarter 2008, Raises Full-Year Guidance for Earnings Per Share and Total Revenues

July 10, 2008

Gen-Probe Announces Webcast of Second Quarter 2008 Earnings Conference Call
Webcasts Webcasts Gen-Probe at Needham & Company Biotechnology and Medical Technology Conference, June 11th
Gen-Probe at William Blair & Company Growth Stock Conference,
June 18th
Q2 2008 Gen-Probe Earnings Conference Call,
July 31st
Gen-Probe Incorporated
10210 Genetic Center Drive
San Diego, CA 92121

Map  |  Terms  |  Privacy  |  Help